Molecular Diagnostic Test (MDT) billing with DEX Z-Code®
Policy governs submission and reimbursement requirements for molecular diagnostic tests billed to UnitedHealthcare Community Plan Medicaid, including mandatory reporting of Palmetto DEX Z-Code identifiers alongside CPT/HCPCS codes for claims on CMS-1500 and UB04 forms.
Tennessee updated and State Specific Lists added for Tennessee (Rapid Genetic Testing codes).
State Exceptions: Kansas Removed.
State Exceptions: Missouri Added.
State Exceptions: Maryland Added.
Reimbursement Guidelines, Definitions, and Q&A sections updated (02/01/2025).
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.